COLUMBUS COUNTY HEALTH DEPARTMENTS
POLICY ON PedvaxHIB IMMUNIZATION
POLICY AND PROCEDURE
Policy Title:
PedvaxHib Immunization Policy and Procedure
Program Area:
Pediatrics
Policy Identifier:
(optional)
Effective Date:
Approval Date:
Revision
Date(s):
Approved by:
Kimberly Smith, Health Director
Approved by:
Hilda Memory, Director of Nursing
6/15/2015
Purpose:
To provide available vaccine to children in Columbus County who qualify.
Definitions:
Columbus County Health Department (CCHD) will provide PedvaxHIB® vaccine in
accordance with immunization laws, schedule, indications/usage, contraindications,
warnings, precautions, m adverse reactions, and dosage/administration. See attachedPackage insert information and Eligibility Criteria
Responsibilities:
Public Health Nurses and Nurse Practitioners
Procedures:
1. PedvaxHIB® is :
 Indicated against invasive diseases caused by Haemophilus influenza type b
in infants and children 2-71 months of age.
 To be administered intramuscularly at 2 months 4 months and 12-15
months of age or as indicated per guidelines.
 NOT recommended for use in infants younger than 6 weeks of age.
 Vaccine should be documented:
a. IN NCIR after it is administered and patient to be given an updated
copy of vaccination record.
b. In the patients personal electronic medical record (CureMD).
Pediatics
Page 1 of 2
COLUMBUS COUNTY HEALTH DEPARTMENTS
POLICY ON PedvaxHIB IMMUNIZATION
POLICY AND PROCEDURE
2. Contraindications:
 Hypersensitivity to any component of the vaccine, including amorphous
aluminum hydroxyphosphate sulfate and sodium chloride. Does not contain
lactose or thimerosal.
 Persons who develop symptoms suggestive of hypersensitivity after an
injections should not receive further injections of the vaccine.
3. Precautions:
 The stopper of the vial contains dry natural latex rubber 13.9% which may
cause allergic reactions.
 Epinephrine (1:1000) must be immediately available should an
anaphylactic or allergic reaction occur. (See CCHD Anaphylaxis Standing
order)
 Vaccination should be delayed during the course of an acute febrile illness.
 Children with impaired immune responsiveness, whether due to
immunosuppressive therapy or HIV, may have reduced antibody response
to Hib. Deferral of administration of vaccine may be considered in these
individuals.
 Minor illnesses such as diarrhea, mild upper-respiratory infection with or
without low grade fever are not contraindications for use of PedvaxHib.
 Conjugate vaccines that contain either diphtheria toxoid or protein should
not be considered as an immunizing agent against diphtheria; no changes
in the schedule for administering DTP are recommended. A conjugate
vaccine that contains meningococcal protein should not be considered as
an immunizing agent against meningococcal disease.
4. Patient/Parents/Guardians Information:
 Vaccine information statement (VIS) from the U.S. Department of Health
and Human Services, Center of Disease Control and Prevention and
National Immunization is given to the patient/parent/guardian (VIS Link)
Reference(s):
Pediatics
Page 2 of 2